T1	Participants 223 319	21 patients with coronary artery disease who were receiving placebo, acebutolol, and propranolol
T2	Participants 513 553	26 patients with chronic angina pectoris
T3	Participants 981 1021	13 patients with stable angina pectoris,
T4	Participants 1286 1302	coronary disease